Literature DB >> 24405156

Regulation of interleukin-6 in head and neck squamous cell carcinoma is related to papillomavirus infection.

Ida Chiara Guerrera1, Ivan Quetier, Rachid Fetouchi, Frederique Moreau, Christelle Vauloup-Fellous, Bouchra Lekbaby, Caroline Rousselot, Cerina Chhuon, Aleksander Edelman, Marine Lefevre, Jean-Claude Nicolas, Dina Kremsdorf, Jean Lacau Saint Guily, Patrick Soussan.   

Abstract

The prevalence of head and neck squamous cell carcinoma (HNSCC) related to human papillomavirus (HPV) is increasing, unlike tobacco- and alcohol-associated cancers. To gain a clearer understanding of the molecular mechanisms implicated in HNSCC, depending on the presence or not of a viral sequence, we investigated the expression of proteins detected in the tumor regions of HNSCC patients. Twenty-two untreated HNSCC patients were selected according to the presence of HPV-16. For six patients, tumor and controlateral healthy tissues were tested for viral detection before quantitative proteomic analysis. After confirmation by Western blot, proteins were connected into a network, leading to investigate interleukin-6 (IL-6) by immunocytochemistry and ELISA. 41 ± 5% of proteins quantified by proteomics were differentially expressed in tumor compared with healthy regions. Among them, 36 proteins were retained as modulated in HPV-16 positive or negative tumors, including cytokeratins, tubulins, annexin A1, and serpin B1. Network analysis suggested a central role of IL-6, confirmed by overexpression of IL-6 in tumor tissues as in sera of HPV-negative HNSCC compared with HPV-16-positive tumors. This modulation may contribute to the survival and proliferation of cancer cells, although it was not related to tumor stage or to the level of HPV-16 DNA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24405156     DOI: 10.1021/pr401009f

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.

Authors:  Hongzheng Zhang; Sungjin Kim; Zhengjia Chen; Sreenivas Nannapaneni; Amy Y Chen; Charles E Moore; Gabriel Sica; Marina Mosunjac; Minh Ly T Nguyen; Gypsyamber D'Souza; Thomas E Carey; Lisa A Peterson; Jonathan B McHugh; Martin Graham; Christine M Komarck; Gregory T Wolf; Heather M Walline; Emily Bellile; James Riddell; Sara I Pai; David Sidransky; William H Westra; William N William; J Jack Lee; Adel K El-Naggar; Robert L Ferris; Raja Seethala; Jennifer R Grandis; Zhuo Georgia Chen; Nabil F Saba; Dong M Shin
Journal:  Head Neck       Date:  2017-09-25       Impact factor: 3.147

2.  Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway.

Authors:  Lusia Sepiashvili; Daryl Waggott; Angela Hui; Wei Shi; Susie Su; Alex Ignatchenko; Vladimir Ignatchenko; Marissa Laureano; Shao Hui Huang; Wei Xu; Ilan Weinreb; John Waldron; Brian O'Sullivan; Jonathan C Irish; Paul C Boutros; Fei-Fei Liu; Thomas Kislinger
Journal:  Mol Cell Proteomics       Date:  2014-09-30       Impact factor: 5.911

3.  IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.

Authors:  L P Stabile; A M Egloff; M K Gibson; W E Gooding; J Ohr; P Zhou; N J Rothenberger; L Wang; J L Geiger; J T Flaherty; J R Grandis; J E Bauman
Journal:  Oral Oncol       Date:  2017-04-09       Impact factor: 5.337

4.  Proteomic analysis of nasal epithelial cells from cystic fibrosis patients.

Authors:  Ludovic Jeanson; Ida Chiara Guerrera; Jean-François Papon; Cerina Chhuon; Patricia Zadigue; Virginie Prulière-Escabasse; Serge Amselem; Estelle Escudier; André Coste; Aleksander Edelman
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

5.  Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma.

Authors:  Jian Gao; Sen Zhao; Trond S Halstensen
Journal:  Oncol Rep       Date:  2016-04-20       Impact factor: 3.906

6.  Label-free LC-MS/MS shotgun proteomics to investigate the anti-inflammatory effect of rCC16.

Authors:  Min Pang; Xin-Yan Bai; Yan Li; Ji-Zhong Bai; Li-Rong Yuan; Shou-An Ren; Xiao-Yun Hu; Xin-Ri Zhang; Bao-Feng Yu; Rui Guo; Hai-Long Wang
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

7.  Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients.

Authors:  Sylvine Carrondo Cottin; Stéphane Turcotte; Pierre Douville; François Meyer; Isabelle Bairati
Journal:  Cancers Head Neck       Date:  2018-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.